v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in Capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024   2,369,797        
Beginning balance at Dec. 31, 2024 $ 754,383 $ 0 $ 2 $ 2,556,095 $ 468 $ (1,802,182)
Beginning balance (in shares) at Dec. 31, 2024     22,004,679      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     183,037      
Issuance of common stock under equity plans 8,640     8,640    
Stock-based compensation expense related to equity-classified awards 20,931     20,931    
Other comprehensive income (loss) (79)       (79)  
Net loss (73,238)         (73,238)
Ending balance (in shares) at Mar. 31, 2025   2,369,797        
Ending balance at Mar. 31, 2025 $ 710,637 $ 0 $ 2 2,585,666 389 (1,875,420)
Ending balance (in shares) at Mar. 31, 2025     22,187,716      
Beginning balance (in shares) at Dec. 31, 2025 2,369,797 2,369,797        
Beginning balance at Dec. 31, 2025 $ 602,689 $ 0 $ 2 2,692,280 873 (2,090,466)
Beginning balance (in shares) at Dec. 31, 2025 22,842,073   22,842,073      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     199,845      
Issuance of common stock under equity plans $ 2,329     2,329    
Stock-based compensation expense related to equity-classified awards 32,618     32,618    
Other comprehensive income (loss) 209       209  
Net loss $ (94,391)         (94,391)
Ending balance (in shares) at Mar. 31, 2026 2,369,797 2,369,797        
Ending balance at Mar. 31, 2026 $ 543,454 $ 0 $ 2 $ 2,727,227 $ 1,082 $ (2,184,857)
Ending balance (in shares) at Mar. 31, 2026 23,041,918   23,041,918